We are international
• myeloma tv TEXT SIZE   

ASH 2011: Dr. Usmani - Phase II Study of Carfilzomib (CFZ) Combined with Other Anti-Myeloma Agents in Relapsed-Refractory Multiple Myeloma (RRMM) - Updates on the UARK Compassionate Use Protocol
Saad Usmani, MD, FACP
Myeloma Institute for Research and Therapy
University of Arkansas for Medical Sciences
Little Rock, Arkansas, USA

To view the video full screen, click on the small button next to the volume control in the lower right hand corner.

 related articles